PIFP
ABBV icon

Partners in Financial Planning’s AbbVie ABBV Stock Holding History

Partners in Financial Planning’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$286K Hold
1,317
– – 0.05% 106
2025
Q4 		$301K Buy
1,317
+1
+0.1% +$228 0.05% 97
2025
Q3 		$305K Hold
1,316
– – 0.05% 93
2025
Q2 		$244K Hold
1,316
– – 0.05% 99
2025
Q1 		$276K Hold
1,316
– – 0.06% 89
2024
Q4 		$234K Hold
1,316
– – 0.05% 97
2024
Q3 		$260K Buy
1,316
+88
+7% +$16.4K 0.05% 93
2024
Q2 		$211K Hold
1,228
– – 0.05% 103
2024
Q1 		$224K Buy
+1,228
New +$212K 0.05% 97

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Partners in Financial Planning's ABBV Position: Q1 2026 in Review

Partners in Financial Planning held its AbbVie (ABBV) position steady in Q1 2026 at 1,317 shares worth $286K. The position accounts for 0.05% of the portfolio, ranked #106.

Partners in Financial Planning first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $305K in Q3 2025. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Partners in Financial Planning held 1,317 shares of AbbVie worth $286K as of Q1 2026.
  • Partners in Financial Planning left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.05% of Partners in Financial Planning's portfolio in Q1 2026, its #106 holding.
  • Partners in Financial Planning first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • Partners in Financial Planning's AbbVie position peaked at $305K in Q3 2025.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Partners in Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.